BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29655028)

  • 1. Modulation of human osteoclastogenesis and osteoblastogenesis by lycopene.
    Costa-Rodrigues J; Fernandes MH; Pinho O; Monteiro PRR
    J Nutr Biochem; 2018 Jul; 57():26-34. PubMed ID: 29655028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of extracellular magnesium extract on the proliferation and differentiation of human osteoblasts and osteoclasts in coculture.
    Wu L; Feyerabend F; Schilling AF; Willumeit-Römer R; Luthringer BJC
    Acta Biomater; 2015 Nov; 27():294-304. PubMed ID: 26318802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.
    Liu G; Ma C; Wang P; Zhang P; Qu X; Liu S; Zhai Z; Yu D; Gao J; Liang J; Dai W; Zhou L; Xia M; Yang H
    Biochem Biophys Res Commun; 2017 Sep; 491(2):388-395. PubMed ID: 28733032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY; Lee KH; Kim YK
    Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
    Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
    J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
    Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
    J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex osteoclastogenic inductive effects of nicotine over hydroxyapatite.
    Costa-Rodrigues J; Rocha I; Fernandes MH
    J Cell Physiol; 2018 Feb; 233(2):1029-1040. PubMed ID: 28407244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk of osteoblast and osteoclast precursors on mineralized collagen--towards an in vitro model for bone remodeling.
    Bernhardt A; Thieme S; Domaschke H; Springer A; Rösen-Wolff A; Gelinsky M
    J Biomed Mater Res A; 2010 Dec; 95(3):848-56. PubMed ID: 20824694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblasts of calvaria induce higher numbers of osteoclasts than osteoblasts from long bone.
    Wan Q; Schoenmaker T; Jansen ID; Bian Z; de Vries TJ; Everts V
    Bone; 2016 May; 86():10-21. PubMed ID: 26921824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carboxymethylcellulose and hydroxypropylmethylcellulose on the differentiation and activity of osteoclasts and osteoblasts.
    Agis H; Beirer B; Watzek G; Gruber R
    J Biomed Mater Res A; 2010 Nov; 95(2):504-9. PubMed ID: 20665677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
    Li L; Sapkota M; Gao M; Choi H; Soh Y
    Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro.
    Karieb S; Fox SW
    Br J Nutr; 2012 Nov; 108(10):1736-45. PubMed ID: 22289672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethyl-2, 5-dihydroxybenzoate displays dual activity by promoting osteoblast differentiation and inhibiting osteoclast differentiation.
    Kwon BJ; Lee MH; Koo MA; Kim MS; Seon GM; Han JJ; Park JC
    Biochem Biophys Res Commun; 2016 Mar; 471(3):335-41. PubMed ID: 26869515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation.
    Kamiya S; Nakamura C; Fukawa T; Ono K; Ohwaki T; Yoshimoto T; Wada S
    J Bone Miner Metab; 2007; 25(5):277-85. PubMed ID: 17704992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.